1![Quarterly newsletter of the MS Trust Open Door MayAlso in this issue Quarterly newsletter of the MS Trust Open Door MayAlso in this issue](https://www.pdfsearch.io/img/99683f5c45b694f42e1028ada9a70a7b.jpg) | Add to Reading ListSource URL: www.mstrust.org.ukLanguage: English - Date: 2015-05-06 11:28:28
|
---|
2![Microsoft Word - stc_information_pack Microsoft Word - stc_information_pack](https://www.pdfsearch.io/img/a267dee3f96dafd153fea931e33bf78b.jpg) | Add to Reading ListSource URL: www.msswindon.org.ukLanguage: English - Date: 2013-04-25 10:17:32
|
---|
3![Treatments for MS: TECFIDERA® (dimethyl fumarate) There are currently nine disease-modifying therapies approved for people with MS in Australia. These therapies, called immunotherapies, work to reduce disease activity i Treatments for MS: TECFIDERA® (dimethyl fumarate) There are currently nine disease-modifying therapies approved for people with MS in Australia. These therapies, called immunotherapies, work to reduce disease activity i](https://www.pdfsearch.io/img/e5fe122a410704d13c9078d08228a20d.jpg) | Add to Reading ListSource URL: www.msaustralia.org.auLanguage: English - Date: 2014-01-21 00:35:16
|
---|
4![Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS in Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS in](https://www.pdfsearch.io/img/32b74aeaf2ed0ede3d6afc884262367e.jpg) | Add to Reading ListSource URL: www.mssociety.org.auLanguage: English - Date: 2015-03-01 21:43:46
|
---|
5![Treatments for MS: Aubagio ® (Teriflunomide) There are currently nine disease-modifying therapies approved for people with MS in Treatments for MS: Aubagio ® (Teriflunomide) There are currently nine disease-modifying therapies approved for people with MS in](https://www.pdfsearch.io/img/5701a111840bc2313df33de8ce04d558.jpg) | Add to Reading ListSource URL: www.msaustralia.org.auLanguage: English - Date: 2014-03-13 00:47:37
|
---|
6![Treatments for MS: Aubagio ® (Teriflunomide) There are currently nine disease-modifying therapies approved for people with MS in Treatments for MS: Aubagio ® (Teriflunomide) There are currently nine disease-modifying therapies approved for people with MS in](https://www.pdfsearch.io/img/2ccf76808b34a3527b1b62475a890dae.jpg) | Add to Reading ListSource URL: www.mssociety.org.auLanguage: English - Date: 2015-03-01 21:43:46
|
---|
7![How rare models suggest new treatment strategies How rare models suggest new treatment strategies](https://www.pdfsearch.io/img/a6ebf05db4e306ae66c8adbeaacb1d6f.jpg) | Add to Reading ListSource URL: medicalxpress.comLanguage: English - Date: 2015-03-03 13:56:00
|
---|
8![Microsoft Word - Novartis release Pipeline Day Dec 2009.doc Microsoft Word - Novartis release Pipeline Day Dec 2009.doc](https://www.pdfsearch.io/img/d67b2f79d58647a9ea4a0cc1e088ba17.jpg) | Add to Reading ListSource URL: hugin.infoLanguage: English - Date: 2009-12-08 16:38:02
|
---|
9![The Retreat of Multiple Sclerosis For the first time, medical treatment has been shown to halt disease progression or even to produce improvement in multiple sclerosis patients By JOAN AREHART-TREICHEL The Retreat of Multiple Sclerosis For the first time, medical treatment has been shown to halt disease progression or even to produce improvement in multiple sclerosis patients By JOAN AREHART-TREICHEL](https://www.pdfsearch.io/img/a967135a5132a9c50ee65dd5dd4e9453.jpg) | Add to Reading ListSource URL: hyperbarictherapycenterofrome.comLanguage: English - Date: 2015-01-13 21:22:42
|
---|
10![Disclosures Biogen Idec Novartis Acorda Disclosures Biogen Idec Novartis Acorda](https://www.pdfsearch.io/img/7f8df2a68facae7e99b6dcd8ab7c4e4b.jpg) | Add to Reading ListSource URL: www.nmhr.orgLanguage: English - Date: 2013-08-03 13:07:36
|
---|